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Introduction
Non-proportional hazards are increasingly observed in
publications of large trials. However, to use or not to
use a method accounting for non-proportional hazards
may be a difficult decision, in the absence of appraisals
of existing methods and the uncertainty in whether
results provide different or more insights into the clini-
cal questions.
Methods
We analyse survival data reconstructed from two trials
publications which reported extreme non-proportional
hazards (with respective p-values as 9.19E-13 and
1.344E-24 in non-PH Grambsch-Thernau test). We use
the Cox proportional hazards model, flexible parametric
model and accelerated failure time model to estimate
the time-independent hazard ratio, between-arm differ-
ence in restricted mean survival time (RMST) and accel-
eration factor as respective summary treatment effect
measures. Estimation of the latter two measures does
not require PH. We also analyse the hazard ratio and
difference in RMST as time-dependent effects.
Results
In this empirical study, the three summary measures
produce broadly similar results on the evidence against
the null hypothesis. Both the Cox model and the flexible
model are able to incorporate time-dependent treatment
effects to account for non-proportional hazards. Flexible
parametric models support plotting of the time-depen-
dent hazard ratio and time-dependent difference in
RMST, which provides useful insights into how the
treatment effect measure may change with time.
Conclusions
Although p-values for the three summary measures have
similar influence on the statistical significance of treatment
effects, using the difference in RMST as the summary
measure emphasizes the often-neglected time-horizon and
allows more intuitive interpretation of the magnitude of
treatment effects.
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